H. pylori infection eradication. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Case group: The high-dose triple therapy group 10 days (Group A) received esomeprazole 40 mg (Ezonium®, Abedi Pharmacy Company), amoxicillin 1 g, and bismuth subcitrate 240 mg, each ad
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients over 18 and under 80 years of age patients who have gastric ulcer, duodenal ulcer, or erosive gastritis, patients who have no previous history of Helicobacter pylori eradication therapy positive H. pylori test confirmed by histopathology or a positive rapid urease test.
Exclusion criteria
Exclusion criteria: Patients with advanced underlying liver and kidney disease. Patients who are unwilling to participate in the study. History of previous Helicobacter pylori eradication treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection detection in patients. Timepoint: “At the time of endoscopy, gastric mucosal biopsies were obtained, and Helicobacter pylori infection was evaluated by histopathological examination.”. Method of measurement: Helicobacter pylori infection evaluation in pathology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Testing and evaluation of Helicobacter pylori eradication. Timepoint: Eight weeks after completion of Helicobacter pylori eradication therapy. Method of measurement: Helicobacter pylori stool antigen test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mohammad Valizadeh Toosi
Mazandaran University of Medical Sciences
Outcome results
None listed